PCBK Relative Valuation - Sesen Bio Inc - Alpha Spread
S

Sesen Bio Inc
F:PCBK

Watchlist Manager
Sesen Bio Inc
F:PCBK
Watchlist
Price: 0.5124 EUR 28.1% Market Closed
Market Cap: 103.9m EUR
Have any thoughts about
Sesen Bio Inc?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of PCBK.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PCBK Relative Value
Base Case
Not Available
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
2.9
Median 5Y
2.8
Industry
7.7
vs History
vs Industry
Median 3Y
-5.8
Median 5Y
-33
Industry
23.9
vs History
vs Industry
Median 3Y
4.5
Median 5Y
-2.3
Industry
22.2
vs History
vs Industry
Median 3Y
4.5
Median 5Y
-2.3
Industry
24
vs History
vs Industry
Median 3Y
0.9
Median 5Y
0
Industry
2.5
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0.1
Industry
7.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.5
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-1.9
Industry
5.1
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-1.9
Industry
4.7
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-2.3
Industry
6.6
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-2.3
Industry
4.7
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
0
Industry
4.7

Multiples Across Competitors

PCBK Competitors Multiples
Sesen Bio Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Sesen Bio Inc
F:PCBK
103.9m EUR 2.9 -5.8 -0 -0
US
Abbvie Inc
NYSE:ABBV
341.9B USD 6.2 64.6 15.8 24.1
US
Amgen Inc
NASDAQ:AMGN
180.5B USD 5.8 57.7 20.2 36.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
127.8B USD 9.5 29.6 25.9 28.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.3B USD 11.9 -251.7 26.8 28.1
US
Gilead Sciences Inc
NASDAQ:GILD
104.5B USD 3.8 99.3 9.4 12
US
Epizyme Inc
F:EPE
94.1B EUR 1 981.8 -505.7 -550.7 -536
AU
CSL Ltd
ASX:CSL
142.3B AUD 6.5 36.7 22.4 27.9
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.5 -63 -56.9
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.4B USD 15.1 -485.3 213.7 328.9
P/E Multiple
Earnings Growth
US
S
Sesen Bio Inc
F:PCBK
Average P/E: 57.5
Negative Multiple: -5.8
N/A
US
Abbvie Inc
NYSE:ABBV
64.6
406%
US
Amgen Inc
NASDAQ:AMGN
57.7
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.6
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -251.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
99.3
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
AU
CSL Ltd
ASX:CSL
36.7
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -485.3 N/A
EV/EBITDA Multiple
EBITDA Growth
US
S
Sesen Bio Inc
F:PCBK
Average EV/EBITDA: 47.7
Negative Multiple: -0
N/A
US
Abbvie Inc
NYSE:ABBV
15.8
28%
US
Amgen Inc
NASDAQ:AMGN
20.2
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.9
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.8
39%
US
Gilead Sciences Inc
NASDAQ:GILD
9.4
10%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -550.7 N/A
AU
CSL Ltd
ASX:CSL
22.4
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -63 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 185.3 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
213.7
N/A
EV/EBIT Multiple
EBIT Growth
US
S
Sesen Bio Inc
F:PCBK
Average EV/EBIT: 69.5
Negative Multiple: -0
N/A
US
Abbvie Inc
NYSE:ABBV
24.1
86%
US
Amgen Inc
NASDAQ:AMGN
36.6
95%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
28.7
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.1
38%
US
Gilead Sciences Inc
NASDAQ:GILD
12
26%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -536 N/A
AU
CSL Ltd
ASX:CSL
27.9
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.9 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 173.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
328.9
N/A

See Also

Discover More
Back to Top